-
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2028 in its research report dated April 11, 2017.
-
ICICI Direct is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1960 in its research report dated January 25, 2017.
-
ICICI Direct recommended hold rating on Ajanta Pharma with a target price of Rs 1780 in its research report dated July 27, 2016.
-
ICICIDirect is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1780 in its research report dated May 02, 2016.
-
ICICIDirect is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target price of Rs 1780 in its research report dated February 3, 2016.
-
Watch the interview of technical analyst, Rajat Bose of rajatkbose.com with Latha Venkatesh and Sonia Shenoy of CNBC-TV18. He shared his reading and outlook on the market and also gave recommendations on various stocks.
-
ICICIdirect.com is bullish on Ajanta Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 1488, in its research report dated May 11, 2015.
-
ICICIdirect.com is bullish on Ajanta Pharmaceuticals and has recommended buy rating on the stock with a target price of Rs 1488, in its research report dated May 11, 2015.
-
Brokerage house Firstcall Research is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target price of Rs 2780 in its research report dated January 31, 2015.
-
ICICIdirect.com is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target price of Rs 3220, in its research report dated January 30, 2015.
-
Firstcall Research is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 2098 in its November 05, 2014 research report.
-
Firstcall Research is bullish on Ajanta Pharma Ltd and has recommended buy rating on the stock with a target of Rs 1758 in its August 28, 2014 research report.
-
Brokerage house Nirmal Bang has recommended hold rating on Ajanta Pharma (APL) with a price target of Rs 1050 in its July 29, 2013 research report.
-
Nirmal Bang is bullish on Ajanta Pharma and has recommended to buy the stock on decline for the target price of Rs 669, in its January 25, 2013 research report.
-
Firstcall Research is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target price of Rs 859 in its August 4, 2012 research report.
-
Nirmal Bang has come out with its report on Ajanta Pharma and recommended to book partial profit.
-
Sunidhi Securities is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 750 in its April 30, 2012 research report.
-
Nirmal Bang is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 409 in its January 24, 2012 research report.
-
Firstcall Research is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 380 in its November 10, 2011 research report.
-
Nirmal Bang is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 401 in its August 12, 2011 research report.
-
Nirmal Bang has maintained hold rating on Ajanta Pharma with a target price of Rs 318 in its July 4, 2011 research report.
-
KRChoksey is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 307 in its May 4, 2011 research report.
-
Nirmal Bang is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 318 in its May 4, 2011 research report.
-
Nirmal Bang is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 295 in its April 08, 2011 research report.
-
Swastika Investmart is bullish on Ajanta Pharma and has recommended buy rating on the stock with a target of Rs 239.90 in its February 10, 2011 research report.
